Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
US FDA Advisory Committee recommends no cardiovascular outcomes trial for peripherally-acting mu-opioid receptor antagonist (PAMORA) class including MOVANTIK
-
AstraZeneca in-licenses Synairgen's SNG001 as a novel immuno-modulatory therapy for viral-induced exacerbation in asthma
-
Brodalumab treatment improved clinical signs and symptoms in Phase II psoriatic arthritis study published in the New England Journal of Medicine
-
AstraZeneca to present new data from its broad portfolio in wide range of patient populations at the American Diabetes Association 74th Scientific Sessions®
-
AstraZeneca’s novel antibiotic candidate AZD0914 given Fast Track status by US FDA
-
AstraZeneca updates on the rapid progress of its oncology pipeline at ASCO 2014
-
Nobel Laureate Tim Hunt to visit China for the Nobel Prize Inspiration Initiative, in partnership with AstraZeneca
-
AstraZeneca welcomes positive data on the combination of olaparib and cediranib for the treatment of ovarian cancer patients
-
Statement regarding Pfizer withdrawal
-
Clarification regarding Pfizer statement
Latest articles and press releases
All of our latest press releases and articles are available to explore
